Accuray, Inc. (NASDAQ:ARAY)

CAPS Rating: 4 out of 5

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

Recs

0
Player Avatar robertshrestha (44.62) Submitted: 12/26/2011 11:13:27 PM : Outperform Start Price: $4.38 ARAY Score: +36.12

Nice growth prospects as uses for CyberKnife system expands, solid balance sheet, beaten-down stock price. What's not to like?!

Featured Broker Partners


Advertisement